Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Ageless Radiance Club

Dr Steven Liew | Specialist Plastic Surgeon | Polynucleotides and Advanced Regenerative Treatments

10 Feb 2025

Description

Dr. Steven Liew, is a globally recognised Specialist Plastic Surgeon and the founder and Chief Medical Officer of Shape Clinic in Sydney. Dr. Liew delves into the future of aesthetic medicine, with a particular focus on the role of regenerative medicine alongside surgical techniques. He highlights the increasing importance of combining various treatments to address the complexities of ageing. Key topics include cutting-edge treatments such as polynucleotides and exosomes, their applications in skin rejuvenation, and the future of personalised, multimodal approaches in aesthetic clinics. Dr Steven Liew (FRACS) Specialist Plastic Surgeon MED0001151298 Key Takeaways: The future of aesthetics lies in a blend of surgical and non-surgical methods. Regenerative medicine is pivotal in advancing aesthetic treatments. Polynucleotides can enhance skin quality and elasticity significantly. Menopause-related skin changes require targeted, specialised treatments. Ageing is increasingly recognised as a condition requiring medical intervention. Exosomes are a powerful tool for promoting skin regeneration. Multimodal treatments will become a cornerstone of aesthetic practice. Fat preservation in the face is key to maintaining a youthful appearance. Combination therapies offer a comprehensive approach to effective treatment. The role of stem cells in regenerative medicine is expanding rapidly. Watch the episode here:https://youtu.be/YUc4cg0bf94See omnystudio.com/listener for privacy information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.